Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Peptides with at least one nonpeptide bond other than a...
Reexamination Certificate
2008-03-31
2010-10-05
Steele, Amber D. (Department: 1639)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Peptides with at least one nonpeptide bond other than a...
C530S330000
Reexamination Certificate
active
07807779
ABSTRACT:
The present invention provides antineoplastic peptides of formula I,in-line-formulae description="In-line Formulae" end="lead"?R1R2N—CHX—CO—A—B-D-E-(G)s-Kin-line-formulae description="In-line Formulae" end="tail"?wherein R1, R2, X, A, B, D, E, G, K and s have the meanings stated in the description. The compounds have antineoplastic activity.
REFERENCES:
patent: 4816444 (1989-03-01), Pettit et al.
patent: 5502032 (1996-03-01), Haupt et al.
patent: 5504191 (1996-04-01), Pettit et al.
patent: 5530097 (1996-06-01), Pettit et al.
patent: 5554725 (1996-09-01), Pettit
patent: 5831002 (1998-11-01), Haupt et al.
patent: 5864012 (1999-01-01), Amberg et al.
patent: 5886147 (1999-03-01), Amberg et al.
patent: 5965700 (1999-10-01), Amberg et al.
patent: 6015790 (2000-01-01), Barlozzari et al.
patent: 6103698 (2000-08-01), Barlozzari et al.
patent: 6143721 (2000-11-01), Janssen et al.
patent: 6248865 (2001-06-01), Amberg et al.
patent: 6458765 (2002-10-01), Janssen et al.
patent: 6632795 (2003-10-01), Barlozzari et al.
patent: 2003/0153505 (2003-08-01), Janssen et al.
patent: 4415997 (1995-11-01), None
patent: 0398558 (1990-11-01), None
patent: 0598129 (1994-05-01), None
patent: WO-92/02541 (1992-02-01), None
patent: WO-93/23424 (1993-11-01), None
patent: WO-95/30690 (1995-11-01), None
patent: WO-95/30691 (1995-11-01), None
patent: WO-96/40751 (1996-12-01), None
patent: WO-96/40752 (1996-12-01), None
patent: WO-97/17364 (1997-05-01), None
Voskoglou-Nomikos et al., 2003, Clinical Predictive Value of the in vitro Cell line, Human Xenograft, and Mouse Allograft Preclinical Cancer Models, Clinical Cancer Research, 9: 4227-4239.
Kingston et al., 2009, Tubulin-Interactive Natural Products as Anticancer Agents, J. Nat. Prod., 72: 507-515.
Bai, R., et al., “Dolastatin 15, a potent antimitotic depsipeptide derived fromDolabella auricularia. Interaction with tubulin and effects on cellular microtubules,”1-Pharmacology Abstract, vol. 117:103735g. p. 41 (1992).
Bai, R., et al., “Structure-Activity Studies with Chiral Isomers and with Segments of teh Antimitotic Marine Peptide Dolastatin 10,”Biochemical Pharmacology, vol. 40(8):1859-1864 (1990).
Miyazaki, K, et al., “Synthesis and Antitumor Activity of Novel Dolastatin-10 Analogs,”Chem. Pharm. Bull., vol. 43(10):1706-1718 (1995).
Pettit, G.R., et al., “Antineoplastic Agents. 220. Synthesis of Natural (−)—Dolastatin 15,”J. Chem. Soc., vol. 113:6692-6693 (1991).
Pettit, G.R., et al., “Antineoplastic Agents 337. Synthesis of Dolastatin-10 Structural Modifications,”Anti-Cancer Drug Design, vol. 10:529-544 (1995).
Pettit, G.R., et al., “Isolation and Structure of the Cytostatic Depsipeptide Dolastatin 13 from the Sea HareDolabella auricularia,” J. Am. Chem. Soc., vol. 111(13):5015-5017 (1989).
Pettit, G.R., et al., “Isolation and Structure of the Cytostatic Linear Depsipeptide Dolastatin 15,”J. Org. Chem. vol. 54:6005-6006 (1989).
Pettit, G.R., et al., “Isolation of Dolastatin 10-15 from the Marine MolluscDolabella auricularia,” Tetrahedron, vol. 49(42):9151-9170 (1993).
Pettit, G.R., et al., “The Dolastatins 20. A convenient synthetic route to Dolastatin 15,”Tetrahedron, vol. 50(42):12097-12108 (1994).
Pettit, G.R., et al., “The Isolation and Structure of a Remarkable Marine Animal Antineoplastic Constituent: Dolastatin 10,”J. Am. Chem. Soc., vol. 109:6883-6885 (1987).
Rasila, Kanwaldeep Kaur et al., “Tasidotin HCl Genzyme,” Current Opinion in Investigational Drugs, vol. 6(6):631-638 (2005).
Amberg Wilhelm
Barlozzari Teresa
Bernard Harald
Buschmann Ernst
Haupt Andreas
Abbott & GmbH & Co. KG
DeConti, Jr. Giulio A.
Lahive & Cockfield LLP
Steele Amber D.
Trinque Brian C.
LandOfFree
Antineoplastic peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antineoplastic peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antineoplastic peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4240117